Top

Published in:

Open Access 01-12-2015 | Letter

Acute kidney injury in cardiac surgery patients receiving hydroxyethyl starch solutions

Authors: Ole Bayer, Konrad Reinhart

Published in: Critical Care | Issue 1/2015

Excerpt

In a retrospective study by a Canadian team [1], pentastarch infusion was a dose-related independent risk factor for acute kidney injury (AKI) after cardiac surgery. In a new retrospective cardiac surgery study by that team [2], 83% of patients received hydroxyethyl starch (HES) 130/0.4. For unexplained reasons, 25 to 43% of patients received both HES 130/0.4 and pentastarch. …

Rioux JP, Lessard M, de Bortoli B, Roy P, Albert M, Verdant C, et al. Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med. 2009;37:1293–8.CrossRef

Frenette AJ, Bouchard J, Bernier P, Charbonneau A, Nguyen LT, Rioux J-P, et al. Albumin administration is associated with acute kidney injury in cardiac surgery: a propensity score analysis. Crit Care. 2014;18:602.CrossRef

Bayer O, Schwarzkopf D, Doenst T, Cook D, Kabisch B, Schelenz C, et al. Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery - a prospective sequential analysis. Crit Care Med. 2013;41:2532–42.CrossRef

Wilkes MM, Navickis RJ. Postoperative renal replacement therapy after hydroxyethyl starch infusion: a meta-analysis of randomized trials. Neth J Crit Care. 2014;18:4–9.

Hartog CS, Natanson C, Sun J, Klein HG, Reinhart K. Concerns over use of hydroxyethyl starch solutions. BMJ. 2014;349:g5981.CrossRef

Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901–11.CrossRef

Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367:124–34.CrossRef

Pro CI, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683–93.CrossRef

Investigators RRTS, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, et al. An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med. 2012;40:1753–60.CrossRef

Title: Acute kidney injury in cardiac surgery patients receiving hydroxyethyl starch solutions
Authors: Ole Bayer
Konrad Reinhart
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: Critical Care / Issue 1/2015
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/s13054-015-0859-z

At a glance: The STEP trials

Springer Medicine

Acute kidney injury in cardiac surgery patients receiving hydroxyethyl starch solutions

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2015

ICU vampires and anemia

Platelet mitochondrial dysfunction in critically ill patients: comparison between sepsis and cardiogenic shock

Effects of terlipressin as early treatment for protection of brain in a model of haemorrhagic shock

Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis

Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study

Rs1800625 in the receptor for advanced glycation end products gene predisposes to sepsis and multiple organ dysfunction syndrome in patients with major trauma